InvestSMART

Echo IQ Limited (ASX: EIQ) - Announcements

Current share price for EIQ : $0.420 0.01 (2.33%)+

ASX company news and announcements for Echo IQ Limited (EIQ) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Echo IQ Limited (EIQ) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Echo IQ Limited (EIQ), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Echo IQ Limited (EIQ)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$315 US FDA Application Lodged 7 May 2024 9:13AM $0.135 $0.425 risen by 214.81%
$315 Quarterly Report 30 Apr 2024 11:47AM $0.110 $0.425 risen by 286.36%
$315 Appendix 4C Cash Flow Report 30 Apr 2024 11:44AM $0.110 $0.425 risen by 286.36%
$315 Response to ASX Query Letter 26 Apr 2024 1:19PM $0.105 $0.425 risen by 304.76%
$315 Notification of cessation of securities - EIQ 5 Apr 2024 12:06PM $0.115 $0.425 risen by 269.57%
$315 Notification of cessation of securities - EIQ 5 Apr 2024 12:03PM $0.115 $0.425 risen by 269.57%
$315 Notification of cessation of securities - EIQ 5 Apr 2024 12:02PM $0.115 $0.425 risen by 269.57%
$315 Notification of cessation of securities - EIQ 5 Apr 2024 12:00PM $0.115 $0.425 risen by 269.57%
$315 Management Update 2 Apr 2024 9:52AM $0.150 $0.425 risen by 183.33%
$315 Completion of US Reader Study 27 Mar 2024 11:44AM $0.113 $0.425 risen by 277.78%
$315 Receipt of Research & Development Tax Incentive 8 Mar 2024 9:32AM $0.110 $0.425 risen by 286.36%
$315 Cleansing Notice 6 Mar 2024 6:49PM $0.110 $0.425 risen by 286.36%
$315 Application for quotation of securities - EIQ 6 Mar 2024 6:40PM $0.110 $0.425 risen by 286.36%
$315 Half Year Accounts 31 December 2023 28 Feb 2024 2:46PM $0.115 $0.425 risen by 269.57%
$315 Appendix 4D 31 December 2023 28 Feb 2024 2:40PM $0.115 $0.425 risen by 269.57%
$315 Notification regarding unquoted securities - EIQ 20 Feb 2024 6:43PM $0.120 $0.425 risen by 254.17%
$315 Resignation of Joint Company Secretary 1 Feb 2024 5:51PM $0.135 $0.425 risen by 214.81%
$315 Notification of cessation of securities - EIQ 1 Feb 2024 5:39PM $0.135 $0.425 risen by 214.81%
$315 Quarterly Report 31 Jan 2024 11:05AM $0.135 $0.425 risen by 214.81%
$315 Appendix 4C Cash Flow Report 31 Jan 2024 11:03AM $0.135 $0.425 risen by 214.81%
$315 RSH: Cardiovascular AI platform integrated into RPM program 25 Jan 2024 8:43AM $0.135 $0.425 risen by 214.81%
$315 EIQ Licenses Software to Respiri - Remote Patient Monitoring 25 Jan 2024 8:34AM $0.135 $0.425 risen by 214.81%
$315 EIQ Appoints Kimber Rothwell as CEO 16 Jan 2024 8:45AM $0.145 $0.425 risen by 193.10%
$315 Business Progress Update 14 Dec 2023 9:02AM $0.150 $0.425 risen by 183.33%
$315 Change of Director's Interest Notice 30 Nov 2023 8:14AM $0.160 $0.425 risen by 165.63%

226 - 250 of 404 results

Page 10 of 17

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.